Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (16 chapters)
-
Front Matter
-
Membrane Transport Mechanisms
-
Front Matter
-
-
Resistance to Alkylating Agents
-
Front Matter
-
-
Resistance to Microtubule Active Drugs
-
Front Matter
-
-
Topoisomerases
-
Front Matter
-
-
Resistance to Endocrine Therapies
-
Front Matter
-
-
Resistance to Retinoids
-
Front Matter
-
About this book
In this volume of Drug Resistance, leading investigators in the field have reviewed the most basic mechanisms of drug resistance, and have proposed ways to modulate resistance. This comprehensive volume should be of value for basic and clinical scientists who wish to delve more deeply into this intriguing problem in the laboratory and devastating problem in the clinic.
Editors and Affiliations
-
The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, USA
William N. Hait
-
Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, USA
William N. Hait
-
Department of Pharmacology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, USA
William N. Hait
Bibliographic Information
Book Title: Drug Resistance
Editors: William N. Hait
Series Title: Cancer Treatment and Research
DOI: https://doi.org/10.1007/978-1-4613-1267-3
Publisher: Springer New York, NY
-
eBook Packages: Springer Book Archive
Copyright Information: Kluwer Academic Publishers 1996
Hardcover ISBN: 978-0-7923-4022-5Published: 30 September 1996
Softcover ISBN: 978-1-4612-8540-3Published: 16 September 2011
eBook ISBN: 978-1-4613-1267-3Published: 06 December 2012
Series ISSN: 0927-3042
Series E-ISSN: 2509-8497
Edition Number: 1
Number of Pages: XVIII, 418
Topics: Oncology, Pharmacology/Toxicology
Industry Sectors: Biotechnology, Health & Hospitals, Pharma